Literature DB >> 9283702

Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus.

F H Marshall1, K Patel, K Lundstrom, J Camacho, S M Foord, M G Lee.   

Abstract

1. The human prostaglandin EP4 receptor has been expressed by use of the Semliki Forest virus system. 2. In cell membranes [3H]-prostaglandin E2 ([3H]-PGE2) bound to a high affinity site with a Kd of 1.12 +/- 0.3 nM and a Bmax of 3.1 +/- 0.3 pmol mg-1 protein. 3. In competition studies the rank order of potency for prostaglandins was PGE2 = PGE1 > > PGE2 alpha = PGI2. 4. The binding of [3H]-PGE2 to cell membranes was inhibited by approximately 60% by the addition of guanylnucleotides, suggesting that this proportion of the receptors was G-protein coupled. 5. [3H]-PGE2 binding was increased by greater than 200% by the addition of divalent cations, with little change in the IC50 of PGE2. 6. In saturation studies removal of divalent cations and addition of GTP gamma S resulted in a 65% reduction in the Bmax with no change in the Kd. These results are consistent with the ligand labelling two states of the receptor R*, a high affinity state and R*G, a high affinity G protein coupled state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283702      PMCID: PMC1564884          DOI: 10.1038/sj.bjp.0701332

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway.

Authors:  Robert J George; Mark A Sturmoski; Shrikant Anant; Courtney W Houchen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-01-03       Impact factor: 3.072

Review 2.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

3.  Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA(B) receptors stably expressed in mammalian cells.

Authors:  A Green; S Walls; A Wise; R H Green; A K Martin; F H Marshall
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.

Authors:  S Pelletier; J Dubé; A Villeneuve; F Gobeil; Q Yang; B Battistini; G Guillemette; P Sirois
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

5.  Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.

Authors:  T L Davis; N A Sharif
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.

Authors:  Richard J Wilson; Gerard M P Giblin; Susan Roomans; Sharron A Rhodes; Kerri-Ann Cartwright; Vanessa J Shield; Jason Brown; Alan Wise; Jannatara Chowdhury; Sara Pritchard; Jim Coote; Lloyd S Noel; Terry Kenakin; Cynthia L Burns-Kurtis; Valerie Morrison; David W Gray; Heather Giles
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

7.  Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.

Authors:  A K Bassil; R A Borman; E M Jarvie; R J McArthur-Wilson; R Thangiah; E Z H Sung; K Lee; G J Sanger
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

8.  Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.

Authors:  H D Blasey; B Brethon; R Hovius; H Vogel H; A P Tairi; K Lundström; L Rey; A R Bernard
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.